by Samme Jancin | Jun 25, 2015
Pearl Pathways announces the hiring of John Lockwood as a Senior Regulatory Compliance Advisor. Lockwood has over 20 years of experience in quality, regulatory, auditing, and purchasing roles in the life sciences industry. In addition to holding a variety of positions...
by Samme Jancin | Jun 24, 2015
The Indiana Small Business Development Center (ISBDC) created Link Indiana to connect entrepreneurs throughout the state. Link Indiana is another way that ISBDC is trying to promote their mission of creating positive impact through guidance and networking for the...
by Samme Jancin | Jun 24, 2015
The National Institute of Health (NIH) is clearly communicating that it plans to find a way to fix the deficiencies found last month at its “Pharmaceutical Development Section” by FDA. Although this is a major step back for the organization, it has already created a...
by Samme Jancin | Jun 24, 2015
After years of European regulators pushing for a new legislation framework and weeks of speculation, the European Council (EC) seems to have made some progress and agreed to approach the new framework for medical devices and IVD (in vitro diagnostics) laws. The...
by Samme Jancin | Jun 24, 2015
Food and Drug Administration (FDA) has determined there is a safety risk if the shape and size of a generic drug is not similar to its reference drug. FDA made suggestions in a guidance last week calling for the original pill and capsules and its generic form to be...
